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Clinical Efficacy of Endovascular Abdominal 
Aortic Aneurysm Repair
Bong-Su  Son,  M.D.*,  Sung  Woon  Chung,  M.D.*,  Chungwon  Lee,  M.D.*,  Hyo  Yeong  Ahn,  M.D.*, 
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Background:  Endovascular aortic aneurysm repair (EVAR) has come into use and been widely extended because 
of the low complication rate and less-invasiveness. This article aimed to describe our experience in the treatment 
of abdominal aortic aneurysm with EVAR. Materials and Methods: A retrospective review was conducted for the 
22 patients who underwent EVAR in a single hospital December 2001 to June 2009. Results: The mean age of 
the patients was 68.5±7.6 years. There were several risk factors and comorbidities in 20 patients (90.9%). The 
mean diameter of the aortic aneurysms was 61.2±12.9 mm. The mean length, diameter, and angle of the aneur-
ysmal neck were 30.5±15.5 mm, 24.0±4.5 mm, and 43.9±16.0
o, respectively. The mean follow-up period of the pa-
tients was 28.8±29.5 months. The 30-day postoperative mortality was none. Seven patients (31.8%) had endoleaks 
during the hospital stay and three patients (13.6%) had endoleaks during the follow-up period. One patient (4.5%) 
died due to a ruptured aortic aneurysm. The cumulative patient survival rates were 88.2%, 88.2%, and 70.6% at 
1, 3, and 5 years of follow-up, respectively. Conclusion: EVAR is currently a safe, feasible procedure for high risk 
patients with abdominal aortic aneurysm because of low postoperative complication and mortality if patients are se-
lected properly and followed up carefully.
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INTRODUCTION
Since  Dubost  et  al.  [1]  performed  successful  abdominal 
aortic  replacement  using  the  homograft  of  a  thoracic  aorta  in 
1952,  surgery  for  aortic  aneurysms  has  become  common. 
Nevertheless, except some aortic aneurysms caused by vascu-
litis,  abdominal  aortic  aneurysms  are  caused  by  athero-
sclerosis in  most  cases, and  thus primarily develop  in elderly 
patients.  Because  many  elderly  patients  have  associated  un-
derlying  comorbidities,  such  as  diabetes  and  hypertension, 
surgical  outcomes  are  occasionally  poor.  To  overcome  such 
problems,  Parodi  et  al.  [2]  performed  endovascular  aortic 
aneurysm  repair  (EVAR)  in  1991, a n d  s u g g e s t e d  a s  a n  a l t e r -
native  treatment  method  for  aortic  aneurysms  in  high  risk 
patients.  As  the  rate  of  early  morbidities  or  mortality  after 
EVAR has been proven lower [3,4], it has been replacing the 
conventional  surgery  especially  in  high  risk  patients. 
However,  there  have  a  small  number  of  reports  on  the  out-Clinical Efficacy of Endovascular Abdominal Aortic Aneurysm Repair
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come  of  EVAR  in  Korea. 
　Therefore,  we  conducted  this  study  to  assess  the  clinical 
usefulness  by  determining  the  characteristic  and  treatment 
outcomes  of  abdominal  aortic  aneurysm  patients  treated  by 
EVAR in a single hospital comparing with the results of oth-
er  investigators.
MATERIALS AND METHODS
1) The subject patients
　Among  patients  diagnosed  with  abdominal  aortic  aneur-
ysms  between  December  2001  and  June  2009,  the  study  was 
conducted on the 22 patients treated by EVAR. The outcomes 
were  assessed  retrospectively.  Aortic  aneurysms  were  diag-
nosed  by  performing  3-dimensional  computed  tomography  on 
all  patients.
　The  indications  for  EVAR  were  as  follows:  the  maximal 
diameter  of  the  abdominal  aneurysm  is  ＞5  cm;  even  if  the 
maximal diameter of  the abdominal aneurysm is ＜5 cm, the 
size  increased  by  ＞0.5  cm  in  the  last  6  months;  patients 
with  symptoms of  an abdominal  aneurysm;  patients  who  pre-
viously underwent abdominal surgery; patients at high risk for 
surgery due to associated diseases as well as old age; and pa-
tients  reluctant  to  undergo  surgery.  The  contraindications  for 
EVAR  were  as  follows:  patients  with  ruptured  abdominal 
aortic  aneurysms;  the  angulation  of  the  proximal  aneurysmal 
neck  was  large  and  thus  unsuitable  for  the  procedure;  the 
length of the proximal aneurysmal neck is ＜10 mm; and pa-
tients  with  a  tortuous  iliac  artery  in  whom  the  installation  of 
stent  grafts  would  be  difficult.  The  adequate  proximal  neck 
length  and  angulation  are  more  than  15  mm  and  less  than 
60
o. However, even if the length and angulation of the aneur-
ysmal  neck  was  less  than  15  mm  or  more  than  60
o,  EVAR 
was  performed  in  cases  in  which  the  risk  for  open  surgical 
repair  was  determined  high  and  EVAR  was  technically 
feasible.
2) Procedural methods
　Prior  to  EVAR,  the  morphological  characteristics  of  the 
aneurysm  were  assessed  by  3-dimensional  computed  tomog-
raphy  and  the  size  of  the  stent  grafts  was  determined.  Con-
ventional  angiography  was  occasionally  performed  if  needed. 
For  cases  in  which  a  common  iliac  artery  aneurysm  was 
demonstrated by preprocedural computed tomography  prior to 
or during procedure, the internal iliac artery was occluded by 
embolization  to  prevent  a  postprocedural  endoleak. 
　Patients  were  placed  in  the  supine  position  on  the  operat-
ing  table,  and  after  skin  preparation  and  draping,  local  anes-
thesia  was  administered  to  the  inguinal  area  with  2% 
lidocaine.  Under  duplex  sonography  monitoring,  the  femoral 
artery  was  assessed,  a  catheter  was  inserted  into  the  abdomi-
nal aorta by Seldinger’s method. By angiography, the location 
and size of the abdominal aorta were assessed again. Through 
the  catheter,  stent  grafts  were  deployed  and  the  presence  or 
absence  of  endoleak  was  assessed  immediately.  If  endoleak 
was detected, balloon dilatation and insertion of another stent 
graft  was  added.  After  completion  of  the  deployment,  the  lo-
cation  of  stent  grafts  and  the  presence  or  absence  of  endo-
leaks  was  assessed  and  the  procedure  was  terminated. 
Whereas mild endoleak was observed by follow-up, persistent 
or  severe  endoleak  was  managed  with  a  secondary  interven-
tion.
3) Follow-up observations
　Computed tomography was performed 1 and 6 months after 
the intervention, and subsequently follow-up observations were 
performed  annually.  We  conducted  a  telephone  survey  with 
each  patient  to  obtain  information  on  their  physical  status.
4) Research methods
　The  medical  records  of  the  patients  were  examined  retro-
spectively,  and  demographic  characteristics,  clinical  character-
istics,  morphologic  characteristics  of  the  aortic  aneurysms, 
characteristics  of  the  procedure,  and  postprocedural  outcomes 
were  assessed.  To  determine  the  demographic  characteristics 
and  clinical  characteristics,  the  gender  and  age  distributions 
were  examined,  and  the  symptoms  and  associated  diseases 
were  examined.
　In  addition,  to  examine  the  morphologic  characteristics  of 
the  aortic  aneurysms,  the  location  and  diameter  of  the  aneur-
ysm, the diameter of the proximal aneurysmal neck, the angle 
and  length  of  the  aneurysmal  neck,  the  shape  of  the  aortic 
aneurysm, and the diameter of the iliac artery were measured. 
The  type  and  number  of  stent  grafts  used,  anesthesia  meth-Bong-Su Son, et al
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Table 2. Morphology of aneurysm
      Morphology  of  aneurysm 
Location  of  disease
    Infrarenal n=22
Diameter  of  aneurysm  (mean±SD)       61.2±12.9  mm
Diameter  of  proximal  neck  (mean±SD)     24.0±4.5  mm
Angle  of  neck  (mean±SD) 43.9±16.0
o
Length  of  neck 
  ＞15  mm n=18  (81.8%)
  ≤15  mm   n=4  (18.2%)
Shape  of  aneurysm
    Fusiform 18  (81.8%)
  S a c c u l a r  4  ( 1 8 . 2 % )
Size  of  Iliac  artery  (mean±SD) 23.1±10.3  mm
Table 1. Patient demographic data and comorbidity
Number  of  patients  (%)
Age  (mean±SD  year) 68.5±7.6
Symptoms
    Asymptomatic  (incidental) 10  (45.4)
    Abdominal  pain   5  (22.7)
    Palpable  mass   4  (18.1)
    Claudication  and  leg  pain   3  (13.6)
  B a c k  p a i n  1  ( 4 . 5 )
    Impotence   1  (4.5)
Comorbidity
    Hypertension 13  (59.0)
    Smoking   9  (40.9)
    Pulmonary  disease   8  (36.3)
    Diabetes  melitus   5  (22.7)
    Heart  disease   3  (13.6)
    Hyperlipidemia   1  (4.5)
    Cerebrovascular  accident   3  (13.6)
    Idiopathic  thrombocytopenic  purpura   1  (4.5)
Prior  abdominal  surgery    6  (27.2)
ods,  and  operative  times  were  assessed.
　To  assess  the  outcomes  of  the  procedure,  the  success  rate 
of  the  procedure,  the  incidence  of  endoleaks  and  reinterven-
tion,  and  mortalities  were  examined.
5) Statistics
　The  statistical  analysis  of  this  study  was  performed  using 
SPSS  17.0  for  Windows  (SPSS  Inc.,  Chicago,  IL,  USA). 
Consecutive  variable  data  were  presented  as  the  mean±devia-
tion  or  the  median  (range),  and  compared  by  a  chi-square 
test.  p-value＜0.05  were  considered  statistically  significant.
RESULTS
　The mean age of patients was 68.5±7.6 years, and the ratio 
of  males-to-females  was  17：5 .  W i t h  r e s p e c t  t o  s y m p t o m s ,  
there  were 10  (45.4%) asymptomatic  incidentally  found  cases 
and  5  (22.7%)  cases  had  abdominal  pain.  Among  all  the  pa-
tients,  15  (68.1%)  had  nonspecific  symptoms.  Hypertension 
was  the  most  prevalent  associated  disease  (59.0%),  followed 
by smoking (40.9%), lung diseases (36.3%), diabetes (22.7%), 
heart  diseases  (13.6%),  and  cerebrovascular  diseases  (13.6%). 
Among all of the patients, 20 (90.9%) had associated diseases 
(Table  1). 
    All  of  the  patients  had  infra-renal  abdominal  aortic  aneu-
rysms.  Eighteen  patients  (81.8%)  had  fusiform  aortic  aneur-
ysms,  and  4  patients  (18.2%)  had  saccular  aortic  aneurysms. 
The  mean  diameter  of  the  aortic  aneurysm  was  61.2±12.9 
mm.  The  proximal  aneurysmal  neck  was  more  than  15  mm 
in  length  in  18  cases  (81.8%),  and  the  mean  length  was 
30.5±15.5  mm.  The  mean  diameter  and  angle  of  the  aneur-
ysmal  neck  was  24.0±4.5  mm  and  43.9±16.0
o,  respectively. 
The  mean  diameter  of  the  iliac  artery  was  23.1±10.3  mm, 
and  in  most  patients,  the  diameter  of  the  iliac  artery  was 
greater  than  in  healthy  individuals  (Table  2).
　T h e  S e p a r a t e  s t e n t  g r a f t  Y - t y p e
Ⓡ  (S&G  Biotech,  Sung 
Nam, Gyung Gi Do, Korea) was used in 1 case, the conven-
tional stent graft I-type
Ⓡ (S&G Biotech) was used in 4 cases, 
the Excluder
Ⓡ (W. L. Gore, Flagstaff, AZ, USA) was used in 
6  cases,  and  the  Zenith
Ⓡ  (Cook,  Inc.,  Minneapolis,  MN, 
USA)  was used  in 11  cases.  EVAR was performed under lo-
cal  anesthesia  with  2%  lidocaine  except  one  case.  The  one 
case  was  performed  under  epidural  anesthesia  for  femo-
ro-femoral  bypass  graft  simultaneously,  because  of  total  oc-
clusion  of  the  common  iliac  artery.  The  average  operative 
t i m e  w a s  1 3 6 . 1 ±28.7  minutes,  and  during  the  procedure,  no 
significant  hemorrhage  or  acute  complications  developed.
　The  hospitalization  period  after  the  procedure  was  7.9±5.4 
days,  the  average  follow-up  period  was  28.8±29.5  months, 
and  none  of  patients  died  within  30  days. 
　The  deployment  success  rate  of  the  procedure  was  100%. 
The complete technical success rate, defined as cases without 
endoleak,  was  68.2%  and  partial  technical  success  rate,  de-Clinical Efficacy of Endovascular Abdominal Aortic Aneurysm Repair
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Table 3. Outcome of endovascular aortic aneurysm repair
Number  of  patients  (%)
Deployment  success  rate 22  (100)
Technical  success  rate
    Partial   7  (31.8)
    Complete 15  (68.2)
Primary  endoleak
  T y p e  I  3  ( 1 3 . 6 )
  T y p e  I I  2  ( 9 . 0 )
  T y p e  I V  2  ( 9 . 0 )
Secondary  endoleak
  T y p e  I I  2  ( 9 . 0 )
  T y p e  I I I  1  ( 4 . 5 )
Reintervention   1  (4.5)*
Open  repair  during  follow-up  period   2  (9.0)
†
*=Due  to  type  III  endoleak; 
†=Due  to  ruptured  aortic  aneurysm.
Table 4. Patients with endoleak
Patient
Primary/
Secondary
Type  of 
endoleak
Device
Length  of
neck  (mm)
Angle  of 
neck  (
o)
Follow-up
period 
(month)
Progression
1 Secondary III Separate  stent  graft 10 47.1 88 Reintervention  due  to  disruption  of  left  iliac  arm 
 Y - t y p e
Ⓡ
2 Primary IV Zenith
Ⓡ 30 52.1 25 Spontaneous  resolved
3 Primary IV Zenith
Ⓡ 32 50 19 Spontaneous  resolved
4 Primary Ib Excluder
Ⓡ 28 49.4 12 Mild  endoleak,  Observation
Secondary II Mild  endoleak,  Observation
5 Primary Ib Zenith
Ⓡ 12 35 10 Spontaneous  resolved
6 Primary Ia Excluder
Ⓡ 14 74.1 10 Resolved  after  rearrangement  of  the  stent  graft
  during  procedure
7 Primary II Zenith
Ⓡ 10 45.6 4 Mild  endoleak,  Observation
8 Primary II Excluder
Ⓡ 76 46.1 4 Spontaneous  resolved
9 Secondary II Excluder
Ⓡ 25 60 3 Mild  endoleak,  Observation
fined  as  cases  with  endoleak  was  31.8%.  Endoleaks  occurred 
in  7  patients  (31.8%)  immediately  after  the  intervention  or 
during  the  hospitalization  period.  I n  o n e  p a t i e n t  w i t h  a  t y p e  
Ia  endoleak,  the  endoleak  resolved  by  rearrangement  of  the 
stent  graft during the  intervention. In  four  cases (one  type  Ib 
patient, one type II patient, and two type IV patients), the en-
doleak  resolved  during  the  follow-up  observation  period. 
Among  the  four  cases,  two  patients  with  type  IV  endoleaks 
had Zenith
Ⓡ stent grafts (Cook, Inc.), and on the imaging ob-
tained  immediately  after  deployme n t  o f  t h e  s t e n t  g r a f t s ,  m i l d  
endoleak  was  detected,  which  had  resolved  on  the  imaging 
obtained 1 month after the intervention. In the remaining two 
cases  (one  type  Ib  patient  and  one  type  II  patient),  mild  en-
doleak  was  persistent  and  they  are  currently  under  follow-up 
observation.  Depending  on  the  clinical  course,  reintervention 
may  be  considered.  Endoleaks  during  the  follow-up  ob-
servation  period  occurred  in  3  p a t i e n t s  ( 1 3 . 6 % ) .  I n  o n e  p a -
tient  with  a  type  III  endoleak,  reintervention  with  stent  graft 
deployment  was  performed  after  19  months  of  follow-up  ob-
servation  due  to  an  endoleak  in  the  left  iliac  artery;  after  5 
years  4  months  of  follow-up  observation,  an  emergency  axil-
lo-bifemoral  bypass  graft  was  performed  due  to  a  ruptured 
aorta.  For  the  remaining  2  cases  (type  II),  because  the  endo-
l e a k  w a s  m i l d ,  t h e  p a t i e n t s  a r e  c u r r e n t l y  u n d e r  f o l l o w - u p  
observation.  After  the  intervention,  surgical  treatment  was 
performed on 2 patients (9.0%) after 5 years 4 months and 4 
years  1  month  due  to  a  ruptured  aorta  (Table  3,  4).  The  in-
cidence  of  endoleaks  in  9  patients  (the  one  patient  has  both 
primary  and  secondary  endoleak)  in  whom  the  length  of  the 
proximal  aneurysmal  neck  was  short  (＜15  mm)  and  the  an-
gle  was  large  (＞60
o)  was  compared  with  13  other  patients. 
In  the  our  study,  a  significant  difference  was  not  detected 
(p=0.135). 
　Three  deaths  (13.6%)  occurred  during  follow-up  observa-
tion. One patient underwent emergency surgery for a ruptured 
aorta after 4 years 1 month of follow-up observation and died 
of  pneumonia  2  months  after  surgery.  The  other  2  patients 
died  of  renal  failure  and  heart  failure  after  10  months  and  8 
months  of  follow-up  observation,  respectively.  These  patients Bong-Su Son, et al
− 146  −
Fig. 1. Kaplan-Meier plot of patient survival. 1YSR=1 year survival 
rate; 3YSR=3 year survival rate; 5YSR=5 year survival rate.
were  not  associated  with  endoleak.  The  1-,  3-,  and  5-year 
survival  rates  were  88.2%,  88.2%,  and  70.6%,  respectively 
(Fig.  1).
DISCUSSION
　Surgical  treatment  for  abdominal  aortic  aneurysms  is  a 
method  of  curative  treatment.  Although  the  surgery  reduces 
the risk of rupture of the aortic aneurysm, the mortality perti-
nent to surgery has been reported to be approximately 2∼8% 
[5].  In fact,  in the  high  risk  group for  surgery,  the morbidity 
is  as  high  as  30%  [6].  Thus,  for  high  risk  patients,  surgical 
t r e a t m e n t  f o r  a b d o m i n a l  a o r t i c  a neurysms  is  a  corresponding 
high  risk  treatment  method.  In  1991,  Parodi  et  al.  [2]  per-
formed  EVAR  on  high  risk  patients  and  reported  good 
results.  Subsequently,  EVAR  was  approved  by  the  Food  and 
Drug  Administration  (FDA)  for  the  purpose  of  treating  ab-
dominal  aortic  aneurysm.  From  the  2000s  when  an  education 
involving  the  procedure  was  actively  promoted,  treatment  of 
abdominal  aortic  aneurysms  with  EVAR  increased  rapidly. 
Recently,  with  the  development  of  smaller  and  more  precise 
devices,  EVAR  is  accepted  as  a  useful  treatment  method  for 
patients  at  high  risk  for  postoperative  complications  and  pa-
tients  refusing  open  surgery. 
　This procedure is suitable for cases in which the length of 
the  proximal  aneurysmal  neck  is  more  than  1∼2  cm,  the 
common  iliac  artery  is  suitable  to  distal  immobilization,  the 
aorta  is  without  excessive  twisting,  and  the  approach  to  the 
appropriate  iliac  artery  is  easy.  According  to  a  Korean  study 
reported  in  2005  [7],  it  has  been  reported  that  11.7%  of 
non-ruptured  abdominal  aortic  aneurysm  patients  were  treated 
by  the  endovascular  abdominal  aortic  aneurysm  repair  proce-
dure.
　The advantages of EVAR are the decrease in mortality, re-
duction  in  morbidity,  shortening  of  the  operative  time,  reduc-
tion  of  hemorrhage  during  the  procedure,  rapid  recovery,  re-
duction  of  the  admission  period  to  the  intensive  care  unit, 
and  less  surgical  stress.  In  our  study,  mortality  directly  re-
lated to EVAR was not detected and significant complications 
were  not  detected  except minor  endoleaks. The  complications 
directly  related  to  the  procedure  included  renal  infarctions, 
endoleaks,  dislocation  of  the  stent  grafts,  infections,  ruptures, 
and  thrombi  within  stent  grafts.  Among  the  complications, 
endoleaks  are  the  most  prevalent  complication,  and  re-
intervention for this has been shown to be the greatest short-
coming  of  EVAR. 
　Endoleaks  can  be  diagnosed  by  the  leakage  of  contrast  to 
the  outside  of  stent  grafts  and  the  inside  of  aneurysms. 
Immediately  after  the  procedure,  the  incidence  is  more  than 
20∼30%.  Nonetheless,  approximately  one-half  of  endoleaks 
resolve spontaneously within the first 6 months. After 1 year, 
endoleaks are detected in approximately 10% of cases [8]. In 
several studies, the incidence of endoleaks and consequent re-
intervention  were  examined.  Sampaio  et  al.  [9]  have  reported 
that  the  endoleak  rate  immediately  after  the  intervention  was 
approximately  35.7%.  The  EUROSTAR  group  [10,11]  re-
ported  the  incidence  as  4.9∼15%.  May  et  al.  [12]  have  re-
ported  that  the  incidence  of  endoleaks  and  the  rate  of  re-
intervention  were 5.4% and 4.7%,  respectively. Matsumura et 
al.  [13]  reported  the  incidence  of  endoleaks  and  the  rate  of 
reintervention  to  be  20%  and  11%  after  24  months  of  fol-
low-up observations. In the our study, the rate of primary en-
doleaks  was  31.8%  and  the  rate  of  secondary  endoleaks  was 
13.6%,  which  are  comparable  to  the  aforementioned  studies.
　According  to  May  et  al.  [12],  in  the  early  postintervention 
period  the  mortality  rate  was  5.6%.  Recently,  due  to  the  im-
provement  in  stent  grafts  and  techniques,  the  mortality  rate 
has  decreased.  Matsumura  et  al.  [13]  used  the  Excluder  and Clinical Efficacy of Endovascular Abdominal Aortic Aneurysm Repair
− 147  −
reported  no  mortality.  The  EUROSTAR  group  [10,11]  re-
ported  a  mortality  rate  of  1.6∼3.2%.  Greenberg  et  al.  [14], 
who used the Zenith, reported a 0.2% mortality rate. In com-
parison with the mortality of open surgery, in which the mor-
tality rate is 5%, the mortality rate of EVAR is comparatively 
low,  thus  confirming  the  safety  of  EVAR.  In  the  our  study, 
early  mortality  related  to  the  intervention  was  0%,  and  mor-
tality  related  to  rupture  of  the  aorta  after  30  days  was  4.5%. 
I n  t h e  D R E A M  a n d  E V A R - 1  t r i a l s ,  i t  h a s  b e e n  r e p o r t e d  t h a t  
the early mortality of EVAR was significantly low, but the 2- 
and  4-year  mortality  rates  were  not  different  from  open  sur-
gery,  and  the  incidence  of  performing  reintervention  was 
higher  in  patients  receiving  intervention  [15].
　Currently,  the  results  of  long-term  follow-up  observation 
w i t h  E V A R  h a v e  n o t  b e e n  r e p o r t e d ,  a n d  i n  c o m p a r i s o n  w i t h  
open  surgical  treatments,  the  incidence  of  reintervention  is 
high,  and  even  after  successful  intervention,  the  necessity  of 
the test for the development of endoleak and consequent finan-
cial  problems  have  not  been  resolved.  By  considering  the  ad-
vantages  as  well  as  shortcomings  of  EVAR,  it  is  thought  that 
treatments applying the procedure should be performed for eld-
erly  patients  in  the  high  risk  group  whose  life  expectancy  is 
more  than  1  year  or  cases  not  suitable  to  surgical  treatment.
CONCLUSION
　To obtain superior treatment outcomes of EVAR compared 
to surgery, precise evaluation of patients and aneurysms prior 
to  the  intervention,  selection  of p a t i e n t s ,  a n d  t h e  r e g u l a r  f o l -
low-up  observation  are  essential.  The  size  of  the  sample 
group  was  small  and  the  follow-up  observation  period  was 
s h o r t ,  a n d  t h u s  i t  m a y  b e  r e q u i r e d  t o  r e v i s e  a n d  c o m p l e m e n t  
the  findings  by  additional  studies  in  the  future.
Provided  that  appropriate  evaluation  and  intervention  are 
performed, EVAR is considered to be a safe and useful treat-
ment  method  for  the  high  risk  surgical  group
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